| Literature DB >> 34149633 |
Mengfan Xu1, Shanhu Hu1, Yiwen Wang1, Tao Wang1, Piotr Dziugan2, Bolin Zhang1, Hongfei Zhao1.
Abstract
Lactobacillus helveticus is a homofermentative lactic acid bacterium. It is widely used in the fabrication of Swiss cheese and other dairy products. The aim of this study was to elucidate the mechanism by which L. helveticus utilizes protein. Lactobacillus helveticus CICC22171 were cultured in two different media with various nitrogen sources. The control contained 20 basic amino acids, while the experimental medium contained casein. De novo transcriptome and isobaric tags for relative and absolute quantification (iTRAQ) proteome analyses were applied to determine how L. helveticus utilizes protein. The casein underwent extracellular hydrolysis via ATP-binding cassette (ABC) transporter upregulation and Mn2+-associated cell envelope proteinase (CEP) downregulation. Sigma factors and EF-Tu were upregulated and Mg2+ was reduced in bacteria to accommodate DNA transcription and protein translation in preparation for proteolysis. Hydrolase activity was upregulated to digest intracellular polypeptides and control endopeptidase genes. In these bacteria, casein utilization affected glycolysis, trehalose phosphotransferase system (PTS), and key factors associated with aerobic respiration and reduced glucose consumption.Entities:
Keywords: Lactobacillus helveticus; mechanism; protein-utilization; proteome; transcriptome
Year: 2021 PMID: 34149633 PMCID: PMC8206810 DOI: 10.3389/fmicb.2021.635685
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
The two chemically defined mediums of CDMA and CDMB.
| CDMA | CDMB | ||
|---|---|---|---|
| 20 basic amino acids | 0.5 g/L each | Casein acid hydrolysate vitamin free | 10 g/L |
| Glucose | 20 g/L | Glucose | 20 g/L |
| Nicotinic acid | 0.001 g/L | Nicotinic acid | 0.001 g/L |
| Calcium pantothenate | 0.001 g/L | Calcium pantothenate | 0.001 g/L |
| Pyridoxal | 0.002 g/L | Pyridoxal | 0.002 g/L |
| Riboflavin | 0.001 g/L | Riboflavin | 0.001 g/L |
| Biotin | 0.001 g/L | Biotin | 0.001 g/L |
| Thiamine | 0.001 g/L | Thiamine | 0.001 g/L |
| Sodium acetate | 6 g/L | Sodium acetate | 6 g/L |
| K2HPO4 | 2 g/L | K2HPO4 | 2 g/L |
| MgSO4 | 0.3 g/L | MgSO4 | 0.3 g/L |
| MnSO4 | 0.15 g/L | MnSO4 | 0.15 g/L |
| Tween-80 | 1.0 ml/L | Tween-80 | 1.0 ml/L |
Figure 1Gene ontology (GO) functional classification of differentially expressed genes (DEGs). (1): biological regulation. (2): cellular component organization or biogenesis. (3): cellular process. (4): developmental process. (5): establishment of localization. (6): localization. (7): locomotion. (8): metabolic process. (9): multi-organism process. (10): multicellular organismal process. (11): negative regulation of biological process. (12): positive regulation of biological process. (13): regulation of biological process. (14): reproduction. (15): response to stimulus. (16): signaling. (17): single-organism process. (18): cell. (19): cell part. (20): macromolecular complex. (21): membrane. (22): membrane part. (23): membrane-enclosed lumen. (24): nucleoid. (25): organelle. (26): organelle part. (27): synapse. (28): virion. (29): virion part. (30): antioxidant activity. (31): binding. (32): catalytic activity. (33): electron carrier activity. (34): enzyme regulator activity. (35): molecular transducer activity. (36): nucleic acid binding transcription factor activity. (37): protein binding transcription factor activity. (38): receptor activity. (39): structural molecule activity. (40): transporter activity.
Figure 2Function analysis of DEGs in B vs. A. (A) means DEGs in biological process (BP); (B) means DEGs in molecular function (MF); and (C) means DEGs in cellular component (CC).
GO and pathway enrichment analysis of B vs. A.
| Gene ontology term | Corrected | |
|---|---|---|
| BP | Translation | 8.37 × 10−15 |
| Gene expression | 4.76 × 10−12 | |
| Cellular protein metabolic process | 1.23 × 10−11 | |
| Protein metabolic process | 1.21 × 10−07 | |
| Cellular macromolecule biosynthetic process | 2.50 × 10−07 | |
| Macromolecule biosynthetic process | 9.61 × 10−07 | |
| Organic substance biosynthetic process | 5.50 × 10−05 | |
| Cellular biosynthetic process | 0.00028 | |
| CC | Organelle | 1.40 × 10−21 |
| Ribonucleoprotein complex | 7.99 × 10−21 | |
| Cytoplasmic part | 3.55 × 10−20 | |
| Macromolecular complex | 1.38 × 10−17 | |
| Ribosomal subunit | 2.64 × 10−06 | |
| MF | Structural constituent of ribosome | 8.16 × 10−26 |
| Structural molecule activity | 2.81 × 10−24 | |
| Pathway | Ribosome | 0.0000000 |
Figure 3Gene ontology classification of different proteins. (A) Biological process, (B) molecular function, and (C) cellular component.
Regulation of DEPs in B vs. A.
| Accession | Description | FC (B vs. A) | ||
|---|---|---|---|---|
| Up | A8YVI1 | Phage integrase-recombinase | 1.26 | 0.009 |
| A8YUE7 | Uracil-DNA glycosylase | 1.28 | 0.011 | |
| A8YTJ2 | Putative pre-16S rRNA nuclease | 1.25 | 0.020 | |
| A8YV49 | Integrase-recombinase | 1.25 | 0.028 | |
| F3MN18 | ABC transporter | 1.25 | 0.038 | |
| A8YV42 | UPF0346 protein | 1.22 | 0.050 | |
| Down | F3MNC9 | Pyrimidine-nucleoside phosphorylase | 0.68 | 0.007 |
| Q8KMP9 | Putative elongation factor Tu (Fragment) | 0.80 | 0.036 | |
| U6F4E4 | PTS family mannose porter, IID component | 0.81 | 0.038 |
GO enrichment analysis of DEPs in B vs. A.
| ID | Description | |
|---|---|---|
| GO:0006464 | Cellular protein modification process | 0.018 |
| GO:0072522 | Purine-containing compound biosynthetic process | 0.019 |
| GO:0009165 | Nucleotide biosynthetic process | 0.021 |
| GO:1901293 | Nucleoside phosphate biosynthetic process | 0.023 |
| GO:0009156 | Ribonucleoside monophosphate biosynthetic process | 0.033 |
| GO:0009127 | Purine nucleoside monophosphate biosynthetic process | 0.039 |
| GO:0009168 | Purine ribonucleoside monophosphate biosynthetic process | 0.039 |
| GO:0006164 | Purine nucleotide biosynthetic process | 0.040 |
| GO:0046653 | Tetrahydrofolate metabolic process | 0.041 |
| GO:0009124 | Nucleoside monophosphate biosynthetic process | 0.043 |
| GO:0090407 | Organophosphate biosynthetic process | 0.045 |
| GO:0009163 | Nucleoside biosynthetic process | 0.045 |
| GO:0042455 | Ribonucleoside biosynthetic process | 0.045 |
| GO:1901659 | Glycosyl compound biosynthetic process | 0.045 |
Figure 4Diagram of the mechanism of the utilization of amino acids (A) and proteins (B) by Lactobacillus helveticus CICC22171. The orange color represents the membrane structure, which includes the phospholipid bilayer, the passive and active transport transporters, and the ATP-binding cassette (ABC) transporters. The boldness of the arrows and the addition of substrates, process enzymes, and products indicate the intensification of the reaction. Green represents the transport of nitrogen sources, spherical represents amino acids, and green ellipse represents proteins. Blue is the central rule. The blue helix is DNA, the straight strand is mRNA, and the blue ellipse is protein. Red indicates carbon source metabolism, ATP transport and amino acid production. The yellow color shows the Fe ion conversion of the electron respiratory chain.